Company
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Headquarters: Verdellino, BG, Italy
Employees: 607
CEO: Mr. Marco Francesco Eigenmann
Market Cap
€189.3 Million
EUR as of July 1, 2025
US$223.5 Million
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Categories
Italy Healthcare Drug Manufacturers—Specialty & GenericItaly Healthcare Italy Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. Its pharmaceutical products include powders and granules, tablets, film-coated tablets, and hard gelatine capsules; and nutraceutical products comprise soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, film-coated tablets, and hard gelatin capsules. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1984 and is based in Verdellino, Italy.
Stocks & Indices
Fine Foods & Pharmaceuticals N.T.M. S.p.A. has the following listings and related stock indices.
Stock: MTA: FF wb_incandescent